v3.26.3
SEGMENT INFORMATION (Tables)
9 Months Ended
Sep. 30, 2026
Segment Reporting [Abstract]  
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Product and Service, Revenue [Table Text Block] The table below shows revenue reported by segment and the geographic location of customers:
   (in thousands) 
   Three
months
ended
September 30,
2026
($)
   Three
months
ended
September 30,
2025
($)
   Nine
months
ended
September 30,
2026
($)
   Nine
months
ended
September 30,
2025
($)
 
                 
Life Sciences segment                
Wellness and lifestyle   7    38    39    56 
White labeling services   321    153    871    793 
Total   328    191    910    849 
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue [Table Text Block] The table below shows the loss before income tax and other (expense)/income categories regularly provided to the CODM in assessing the Company’s one reportable segment, “Life Sciences,” segment performance:
   (in thousands)
Three months ended
September 30,
 
   2026
($)
   2025
($)
 
United States (U.S.)        
Revenue   328    191 
Cost of revenue   (267)   (92)
Selling, general, and administrative expenses   (551)   (800)
Research and development expenses   (443)   (846)
Common stock-based compensation and expenses, net   (371)   (686)
Operating loss   (1,304)   (2,232)
Others          
Selling, general, and administrative expenses   (220)   (276)
Research and development expenses   (388)   (347)
Common stock-based compensation and expenses, net   (19)   (44)
Operating loss   (627)   (667)
Total Operating loss   (1,931)   (2,899)

   (in thousands)
Nine months ended
September 30,
 
   2026($)   2025($) 
United States (U.S.)        
Revenue   910    849 
Cost of revenue   (746)   (442)
Selling, general, and administrative expenses   (1,952)   (1,697)
Research and development expenses   (1,663)   (1,891)
Common stock-based compensation and expenses, net   (1,985)   (1,382)
Operating loss   (5,436)   (4,563)
Others          
Selling, general, and administrative expenses   (624)   (677)
Research and development expenses   (953)   (722)
Common stock-based compensation and expenses, net   (160)   (255)
Operating loss   (1,737)   (1,654)
Total Operating loss   (7,173)   (6,217)
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Table Text Block] The table below shows the non-current assets other than financial instruments held in the country of domicile and foreign countries.
   (in thousands) 
Nature of assets  USA
(Country
of Domicile)
($)
   Foreign
Countries
(India and
Colombia)
($)
   Total
as of
September 30,
2026
($)
 
Intangible assets, net   5,740    -    5,740 
Property, plant, and equipment, net   1,969    62    2,031 
Claims and advances   410    242    652 
Operating lease asset   -    -    - 
Total non-current assets   8,119    304    8,423 

   (in thousands) 
Nature of assets  USA
(Country of
Domicile)
($)
   Foreign
Countries
(India and
Colombia)
($)
   Total
as of
December 31,
2025
($)
 
Intangible assets, net   5,101    -    5,101 
Property, plant, and equipment, net   2,073    68    2,141 
Claims and advances   410    259    669 
Operating lease asset   -    11    11 
Total non-current assets   7,584    338    7,922